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a b s t r a c t
Staphylococcus aureus (SA) remains a major cause of nosocomial and community-acquired
infections worldwide. Nasal carriage of this bacterium among hospital personnel consti-
tutes an important source for nosocomial infections. A cross-sectional study enrolling the
whole medical student population (n=387) of the School of Medicine at the Universidad
de Cartagena, Colombia, was conducted to evaluate the carriage rates of both methicillin
sensitive- and methicillin resistant-SA, the frequency of Panton-Valentine leukocidin genes
in the isolates, and risk factors associated with carriage in this selected population. After
signing an informed consent, participants completed a survey related to possible risk factors
for colonization, and nasal swabs were collected from anterior nares. Staphylococcus aureus
strains isolated from carriers were subjected to DNA extraction and PCR assays to determine
the presence of MecA and Panton-Valentine leukocidin genes. Typing of the staphylococcal
chromosomal cassette was performed for methicillin resistant strains. Molecular analysis
wasperformed for only one strain per carrier. Prevalence of carriage formethicillin sensitive-
and methicillin resistant-SA was 25% and 1.6% respectively. Most of the methicillin resistant
isolates carried the staphylococcal chromosomal cassette type IV and the genes for Panton-
Valentine leukocidin. To determine carrier types among medical students, each participant
was subjected to four additional swabs, each taken twoweeks apart. 9.8%persistent carriers,
53.1% intermittent carriers, and 37.1% non-carriers of SA were found. There was no associa-
tion between risk factors analyzed and carriage of the bacterium. The study was conducted
from April to September 2009 and found a persistent carriage of methicillin resistant-SAstrains bearing the genes for Panton-Valentine leukocidin amongmedical students, evidenc-
ing the potential contribution of this portion of healthcare personnel either to the spread
or introduction of these strains into the healthcare environment.
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Introduction
Staphylococcus aureus (SA) remains an important human
pathogen responsible for health care- and community-
associated infections, which also behaves as a commensal
in healthy individuals, adopting the anterior nares as its
ecological niche.1,2 A worldwide concern in public health is
the emergence of methicillin-resistant SA (MRSA) strains,
ﬁrst considered to be conﬁned to hospitals and medical
centers and nowadays presenting in community settings.
Cases of MRSA infections have been increasingly reported
during the last decade in healthy individuals of the gen-
eral population with no traditional risk factors for these
community-associated MRSA (CA-MRSA) infections.3–5 CA-
MRSA strains have been identiﬁed as highly clonal and
virulent, responsible for over 30% of SA infections.6–8
It is well-known that nasal colonization constitutes a risk
factor for subsequent severe infection, but it also can be the
source of transmission of this bacterium to other susceptible
individuals.1,9 Asymptomatic carriage of SA in healthy indi-
viduals has been shown to have a high prevalence, especially
in children, young adults, and healthcare workers.10–12 Thus,
colonized individuals in frequent contact with the general
community or healthcare environment may spread the bac-
teria to other community members or to susceptible patients,
respectively.13–16 Medical students represent an important
portion of the healthcare personnel, and they are in frequent
contact with patients; thus, they are at risk of being colo-
nizedwith different pathogens, including SA, and of spreading
them to susceptible patients.17,18 Different studies around the
world17–21, in Colombia,22 and Brazil23 have evaluated nasal
carriage rates of SA inmedical students. Some of these studies
reported that nasal carriage rates of SA increased with greater
exposure of students to the hospital environment.17,20
Although still a matter of debate, both epidemiological
and clinical studies point out that the high virulence poten-
tial of CA-MRSA originates from Panton-Valentine leukocidin
(PVL), a two-component cytotoxin that targets human and
rabbit polymorphonuclear neutrophils, and monocytes or
macrophages, or both.3,24,25 Furthermore, recent studies indi-
cate that the clinical sequelae of infections caused by
PVL-positive SA strains, regardless of methicillin resistance,
tend to bemore severe than infections caused by PVL-negative
strains.24,26,27
Although the role of PVL in CA-MRSA pathogenesis is still
controversial, epidemiological and clinical data5,24 provide
strong evidence that the high virulence potential of CA-MRSA
is associatedwith the genes lukS-PV and lukF-PV encoding the
subunits of PVL.
It has been shown that CA-MRSA isolates associated
with disease carry the genes for PVL more frequently than
CA-MRSA associated to asymptomatic colonization.28 Thus,
carriers of CA-MRSA strains positive for PVL genes may pose
an increased risk of spreading disease-causing strains to sus-
ceptible individuals. Furthermore, recent studies in different
parts of the world have reported the asymptomatic carriage of
MRSA strains positive for PVL genes inmedical students, a fact
that may contribute to the spread of MRSA between the com-
munity and hospitals.29 In contrast, in Colombia, there are no12;16(4):329–334
data about the frequency of PVL genes innasal isolates inmed-
ical students or other health care workers. Thus, this study
aimed to investigate nasal carriage of PVL-positive SA strains,
carriage categories, and risk factors associated to coloniza-
tion, in medical students from the Universidad de Cartagena,
Colombia during 2009.
Material and methods
Design and study population
The studywas performed fromApril to September, 2009 by the
Genetics and Molecular Biology Research Group of the Univer-
sidad de Cartagena. This was a cross-sectional study enrolling
the entire student population of the School of Medicine at the
Universidad de Cartagena, Colombia, comprising 387 medi-
cal students, of which 372 completed the study. Students who
agreed to participate were asked to sign an informed con-
sent and complete a written questionnaire on demographics
and medical history. Variables included in the questionnaire
were age, gender, previous infections, allergies and other non-
infectious pathologies, smoking habits, antibiotic usage in the
previous three months, and surgeries and hospitalizations in
the previous sixmonths. The studywas approved by the Ethics
Review Board of the Universidad de Cartagena.
To determine SA carriage types in the study population,
participants were subjected to four additional consecutive
nasal swabs, each taken two weeks apart. Based on microbio-
logical results, individuals were classiﬁed in three categories:
non carriers, intermittent carriers, and persistent carriers,
according to the deﬁnitions proposed by Kluytmas et al.9 Par-
ticipants that yielded a total of ﬁve negative cultures for SA
were classiﬁed as non-carriers; those yielding one to three
positive cultures were classiﬁed as intermittent carriers; and
those yielding four or ﬁve positive cultures were classiﬁed as
persistent carriers.
Specimen collection
For each participant, nasal swabs were taken from both
nostrils, inoculated into Stuart’s transport medium (OXOID,
England), transported to the Laboratory of Microbiology of
the School of Medicine at the Universidad de Cartagena,
and processed within eight to 18hours according to previ-
ously described protocols.30 Brieﬂy, specimens were plated
onto mannitol-salt agar (BBL – Becton, USA) and incubated at
35 ◦C–37 ◦C for 48hours; mannitol-salt positive colonies were
subcultured onto nutrient agar (Difco –Michigan, USA) at 37 ◦C
for 24–48hours. Identiﬁcation of SA was based on colony mor-
phology, gram stain, catalase test, tube coagulase test (BBL,
coagulase plasma rabbit – Becton, USA), and latex agglutina-
tion test (Staphaurex – Remel, UK).
Antibiotic susceptibility testingAntibiotic susceptibility of SA strains was performed by
the disc diffusion method following the recommendations
of the Clinical and Laboratory Standards Institute (CLSI).31
The antibiotics evaluated were: rifampin, clindamycin,
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rythromycin, gentamicin, trimethoprim/sulfamethoxazole,
efoxitin, and oxacillin. The D-zone test for inducible
lindamycin resistance was performed for each isolate
ccording to the CLSI method.31 Isolates were classiﬁed as
RSA if they demonstrated resistance to cefoxitin, and as
ethicillin-susceptible SA (MSSA) if they were susceptible.
or methicillin-resistant strains, susceptibility to vancomycin
as further evaluated by the agar dilution method31 at con-
entrations of 0.5 to 32g/mL, and MICs were measured
anually after 24h of incubation. The SA strains ATCC-29213
vancomycin-sensitive), ATCC-25923 (MSSA) and ATCC-33591
MRSA) were used as control strains. MSSA and MRSA iso-
ates were maintained frozen at -35 ◦C for use in subsequent
olecular assays.
olecular analysis
enomic DNA extraction
enomic DNA from each isolate included in the study was
btained according to the protocol described by Millar et al.,32
ith some modiﬁcations. Brieﬂy, each SA isolate was streaked
n nutrient agar and incubated for 24h at 37 ◦C. Five colonies
ere then suspended in 1mL of Tris 0.5M, centrifuged at
3,000 rpm x 5min. Supernatant was discarded and the pel-
et resuspended in 500L buffer TE (10mM Tris; 1mM EDTA,
H:8.0) and boiled at 100 ◦C for 30min, and then incubated at -
5 ◦C for 20minutes, thawed at 65 ◦C, and ﬁnally centrifuged at
3,000 rpm for 15min. Supernatant containing bacterial DNA
as collected in a clean tube and stored at -20 ◦C for subse-
uent PCR assays.
etection of Nuc, MecA and PVL genes
A isolates identiﬁed by microbiological methods were sub-
ected tomultiplex polymerase chain reaction assays to assess
he presence of lukF-PV (encoding part of the PVL toxin),mecA
methicillin resistance determinant), and nuc genes using a
et of three primer pairs: MecA1F – MecA2R that ampliﬁes a
47bp fragment of mecA gene;33 Nuc1F – Nuc2R that ampliﬁes
300bp fragment of nuc gene speciﬁc for SA,34 and LukPV1F
LukPV2R that ampliﬁes a 437bp fragment of PVL gene.25 SA
trains ATCC 33591 (mecA +; nuc +; PVL −) and ATCC 25923
mecA −; nuc +; PVL +) were used as controls for mecA and
VL ampliﬁcation and pure water was used as control for the
CR assay.
yping of SCCmec element
ll conﬁrmed MRSA isolates were subjected to SCCmec typing
sing a multiplex PCR assay in accordance with the proto-
ol described by Zhang et al.33 using the SA control strains
CTC10442 (SCCmec type I), N315 (SCCmec type II), and
CSC4744 (SCCmec type IV).
For each PCR assay, DNA from each isolate was ampliﬁed
n a reaction volume of 25L containing 12.5L of the PCR
ix (PCR master mix; Promega®), 0.2 uM of each primer, and
L of DNA template. The reaction was performed in a Perkin-
lmer thermal cycler under the following conditions: an initial
enaturation step at 94 ◦C for 5min, followed by 30 cycles of
4 ◦C for 1min, 50 ◦C for 1min, and 72 ◦C for 2min, with a ﬁnal
xtension at 72 ◦C for 10min. PCR products were visualized2;16(4):329–334 331
in a 2% agarose gel stained with ethidium bromide under UV
transillumination.
Statistical analysis
Statistical analysis was performed with the Statistical Pack-
age for Social Sciences (SPSS) version 18.0 for Windows (SPSS
Inc. – Chicago, IL). To determine the prevalence of SA nasal
carriage, the study population was classiﬁed as carrier and
non-carrier based on microbiology results obtained from the
ﬁrst nasal swab survey. Conversely, carrier types (non-carrier,
persistent carrier, and intermittent carrier) were determined
at the end of the study based on the deﬁnitions by Kluytmas
et al.9 Univariate analysis was applied to determine the asso-
ciation of colonization or carrier types to potential risk factors
using the chi-square test, with a p-value≤ 0.05 for statistical
signiﬁcance.
Results
A total of 372 participants from the entire medical student
population, comprised by a total of 387 students during the
study period, were surveyed. The age of the participants
ranged between 15 and 26 years (average 19 years, SD: ±2.21).
At the ﬁrst nasal swab survey, SA was isolated from 101
(27.15%) of the 372 participants; six (1.61%) participants were
MRSA carriers, and 95 were MSSA carriers (25.5%). There
was no statistical association with age (p=0.752) or gender
(p=0.275). Furthermore, risk factors including contact with
patients, previous hospitalizations, antibiotic usage, nasal
abnormalities, allergic diseases (asthma, sinusitis, and rhini-
tis), smoking habits, and years of study at the university, were
not associated to nasal carrier state of SA.
The 101 SA strains obtained at the ﬁrst nasal swab survey
were subjected to antibiotic susceptibility testing and molec-
ular analysis. Six isolates were resistant to oxacillin (5.9%);
three were resistant to clindamycin (2.97%), and 15 were resis-
tant to erythromycin (14.85%), one of which had the inducible
clindamycin resistance phenotype (D-zone test positive).
No strain showed resistance to gentamicin, trimethoprim-
sulfamethoxazole, or rifampin. None of the six MRSA strains
were resistant to vancomycin (MIC<0.5g/mL); one MRSA
strain was erythromycin-resistant.
PVL genes were found in only four of the 95 MSSA strains,
and in ﬁve of the six MRSA strains (Fig. 1). SCCmec typing of
the MRSA strains showed that ﬁve carried the SCCmec type IV.
The remainingMRSA strainwas SCCmec type I (Fig. 2). The ﬁve
MRSA strains bearing SCCmec type IV were also PVL-positive,
while the strain bearing SCCmec type I was PVL negative.
Thus, PVL genesweremore frequently carried byMRSA strains
than by MSSA strains (5/6 vs. 4/95, p≤ 0.0001).
In addition, to determine SA carrier types in the study pop-
ulation, the 372 participants were subjected to four additional
consecutive nasal swabs, each taken three weeks apart. From
the 372 students subjected to ﬁve nasal swabs, 9.7% (n=36)
were persistent carriers, 53.2% (n=198) were intermittent car-
riers, and 37.1% (n=138) were non-carriers. Three persistent
carriers were colonized with MRSA strains that carried the
332 braz j infect d i s . 20
L1 L2 L3 L4 L5 L6 L7
←PVL
←nuc
←mec
500 pb→
300 pb→
100 pb→
Fig. 1 – Multiplex PCR for detection of nuc, mecA, and PVL
genes. Multiplex PCR was performed to detect the presence
of nuc, mecA and PVL genes in isolates from medical
students to conﬁrm Staphylococcus aureus species (nuc
gene), methicillin resistance (mecA gene) and presence of
PVL genes. Lane 1: MW (DNA molecular weight markers).
Lane 2: ATCC 33591 reference strain (nuc+, mecA+, PVL-).
Lane 3: ATCC 25923 reference strain (nuc+, mecA-, PVL+).
Lanes 4 to 6: MRSA isolates from the study. Lane 7: negative
control for the PCR reactions.
L1 L2 L3 L4 L5 L6 L7 L8 L9 L10 L11 L12
600 pb→
400 pb→
300 pb→
200 pb→
Fig. 2 – Multiplex PCR assay for SCCmec typing of SA
isolates. Multiplex PCR was performed for typing of the
SCCmec element in MRSA isolates from the study. Lanes 1
and 12: MW (DNA molecular weight markers). Lane 2:
NCTC10442 reference strain (SCCmec type I). Lane 3: N315
reference strain (SCCmec type II). Lane 4: JCSC4744
reference strain (SCCmec type IV). Lanes 5 to 9: MRSA
isolates from medical students carrying SCCmec type IV.
Lane 10: MRSA isolate from a medical student carrying
SCCmec type I. Lane 11: negative control for the PCR assay.
genes for PVL and SCCmec type IV, and they represented med-
ical students enrolled in semesters with clinical rotations.
Discussion
In Colombia there are few reports about the prevalence of
SA carriage in medical students,22 and reports on CA-MRSA
colonization in individuals without risk factors associated to
30,35healthcare are scarce. Traditionally, colonization by MRSA
has been evaluated and described in healthcare personnel, or
individuals that have contact with these institutions or their
workers (physicians, nurses, hospitalworkers, etc.). This study12;16(4):329–334
found that 1.61% of medical students from the Universidad
de Cartagena carried in their nares, persistently or intermit-
tently, MRSA strains with the community-associated proﬁle
(PVL-positive and SCCmec type IV), providing evidence that
these strain types are circulating in the healthcare personnel
in Cartagena. Previous studies in Colombia have shown MRSA
colonization rates in the pharynx, nares, and on the hands
similar to those reported here. For example, Ganoa et al.22
reported that 1.3% of medical students in clinical rotations
carried MRSA strains in their nares, and Baez et al.35 recently
reported that 0.6% of individuals from the general population
with no apparent exposure to healthcare environment and
no antibiotic usage in the previous six months carried CA-
MRSA strains on their hands. Although the rates for MRSA
carriage in healthcare personnel are relatively low, they are
signiﬁcant, since they provide evidence of colonization at dif-
ferent anatomical sites by CA-MRSA both in individuals from
the general population and in medical students who are in
close contact with patients during their clinical rotations in
different hospital centers. This constitutes an important risk
factor for spreading of the pathogen to patients and to the
general population.
The present results are similar to those shown in interna-
tional studies. For example, studies from United States have
reported up to 1.53% of intermediate resistance to methicillin
in SA isolates from medical students in ﬁrst and third year.36
In Chile, Cifuentes et al.37 found that around 5.2% of medi-
cal students participating in their study were nasal carriers of
MRSA. Baliga et al.,38 in Turkey, reported that 4.4% of medi-
cal students in clinical practice were MRSA carriers. In Brazil,
Prates et al.23 reported that the prevalence of CA-MRSA nasal
carriage in university students was 2.4%.
In Colombia, several studies have shown PVL-positive
SA strains, both MSSA and MRSA, as important source of
infections of varying severity,39–41 evidencing an increasingly
serious public health problem in this country. Thepresent data
show thatMRSA isolates frommedical students share features
of CA-MRSA (Figs. 1 and 2), warning about the potential risk for
introduction of these strains to the healthcare environment.
Published evidence42,43 points out that health-careworkers
more likely act as vectors and not as themain sources ofMRSA
transmission; thus emphasizing that good hand hygiene prac-
tices remain essential to control the spread of MRSA. In
addition, eradication of MRSA colonization from patients and
healthy carriers has been tried with topical and oral antibi-
otics. For example, international guidelines recommend the
use of mupirocin for nasal decolonization in certain groups
of patients and health-care workers colonized with MRSA.44
However, this antibiotic is only effective at removing the bac-
terium from the nose over a few weeks, and nasal relapses are
common within several months.45 Moreover, clinical studies
have found little or no efﬁcacy of mupirocin treatment in pre-
venting nosocomial SA infections.46–48 Another shortcoming
for this antibiotic is the increasing trend in resistance and the
subsequent reduction in effectiveness.49,50
Since there are no recommended guidelines for routine
decolonization of CA-MRSA in healthcare workers, especially
medical students, and the authors were concerned about the
reported rise in bacterial resistance to mupirocin, the most
used antibiotic for nasal decolonization, it was decided not to
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ecommend any sort of medical therapy to the group of CA-
RSA carriers in the student population. Instead, the three
ersistent CA-MRSA carriers identiﬁed in this studywere noti-
ed about their colonization status and invited to participate
n an educational session with emphasis on hand hygiene and
tandard precautions for proper handling of patients, aimed
o decrease spread of the bacterium and to reduce the risk of
nfection in susceptible patients.42,51
onclusions
A-MRSA carriage was found in this medical student popula-
ion, and PVL genes were signiﬁcantly carried by these MRSA
trains compared to MSSA strains (p≤ 0.0001). The different
arrier types of SA colonization in medical students from this
niversity were also identiﬁed. The high frequency of SA car-
iage (persistent and intermittent) found in this study may
epresent a risk for the spreading of SA strains, including
RSA strains, from the healthcare personnel to susceptible
atients and to other individuals in the community.52 The
resent study demonstrates that medical students from this
eographical area asymptomatically carry MRSA strains per-
istently, mainly PVL-positive, with the threat of spreading
hem both to community and hospital environments.
Studies addressed to determine the duration of CA-MRSA
arriage, transmissibility, attack rates, and eradication strate-
ies are required to clarify the role of health-care workers,
ncluding medical students, as reservoirs and vectors of these
trains in health-care facilities.51 In addition, the reported
ncrease in bacterial resistance to mupirocin, with its sub-
equent reduction in effectiveness, emphasizes the need for
urther studies aimed to develop strategies to successfully dis-
upt transmission of CA-MRSA strains to susceptible hosts.
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